Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels

FEBS Letters

Volumn 520, Issue 1-3, 2002, Pages 167-170

  Asai, Tomohiro ^a   Shimizu, Kosuke ^a   Kondo, Masami ^a   Kuromi, Koichi ^a   Watanabe, Koh ^a   Ogino, Koichi ^b   Taki, Takao ^b   Shuto, Satoshi ^c   Matsuda, Akira ^c   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Active targeting; Angiogenesis; Anti neovascular therapy; CNDAC; Drug delivery system; Liposome

Indexed keywords

2' C CYANO 2' DEOXY 1BETA DEXTRO ARABINOPENTOFURANOSYLCYTOSINE; 5' O DIPALMITOYLPHOSPHATIDYL 2' C CYANO 2' DEOXY 1BETA DEXTRO ARABINOPENTOFURANOSYLCYTOSINE; ANTINEOPLASTIC AGENT; LIPOSOME; PROTEIN; PROTEIN APRPG; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENDOTHELIUM CELL; LIFESPAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TARGET CELL DESTRUCTION;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; CYTARABINE; DRUG DELIVERY SYSTEMS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PHOSPHATIDIC ACIDS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 18444370257     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)02821-1     Document Type: Article

References (21)

1. Current Pharm